Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?

Saved in:
Bibliographic Details
Title: Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?
Authors: Backes, F.1, Richardson, D.2, McCann, G.1, Salani, R.1, Eisenhauer, E.1, Fowler, J.1, Copeland, L.1, Cohn, D.1, O'Malley, D.1
Source: Gynecologic Oncology. Mar2012 Supplement, Vol. 125, pS94-S94. 1p.
Database: Academic Search Ultimate
Description
ISSN:00908258
DOI:10.1016/j.ygyno.2011.12.226